UK markets closed
  • FTSE 100

    +59.28 (+0.85%)
  • FTSE 250

    +206.11 (+0.91%)
  • AIM

    +4.45 (+0.36%)

    -0.0013 (-0.11%)

    -0.0013 (-0.10%)

    +227.56 (+0.92%)
  • CMC Crypto 200

    -7.40 (-0.93%)
  • S&P 500

    +44.31 (+1.01%)
  • DOW

    +238.20 (+0.68%)

    +0.26 (+0.36%)

    -3.30 (-0.18%)
  • NIKKEI 225

    +159.80 (+0.58%)

    -401.86 (-1.45%)
  • DAX

    +154.75 (+1.00%)
  • CAC 40

    +87.23 (+1.35%)

Antibiotics Market Report 2021-2031

·5-min read

Forecasts by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-AC, Others), by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Gender (Male, Female), by Age (0-14 Years, 15-54 Years, 55 Years and Above), by Route of Administration (Oral, Intravenous, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antibiotics Companies AND COVID-19 Recovery Scenarios

New York, July 02, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Antibiotics Market Report 2021-2031" -

Ageing Population to Offer Lucrative Growth Prospects for Antibiotics Market Players

Adults over the age of 65 are widely regarded as one of the most vulnerable segments of the population. The world is approaching a demographic tipping point. Since the dawn of humanity, young children have outnumbered their parents. Within five years, however, the number of people aged 65 and up would outnumber children under the age of five. Because of falling fertility rates and substantial rises in life expectancy, population ageing would continue, if not intensify. According to the World Health Organization, the number of people aged 65 and up is expected to rise from 524 million in 2010 to nearly 1.5 billion in 2050, with the majority of the increase occurring in developing countries.

Growing Burden of Infectious Diseases to Fuel Antibiotics Market Growth

The growing burden of bacterial infections is projected to fuel the antibiotics market over the forecast period. The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support the market’s healthy growth over the forecast period from 2021 to 2031.

UNIQUE COVID-19 VARIATIONS- only available in this report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 affects the economy.

Which Factors are Fueling Antibiotics Industry Growth?
. Growing Burden of Infectious Diseases to Fuel Market Growth
. Rising Ageing Population Patient Pool to Drive Growth
. Adoption of Digital Health Technology to Boost Antibiotics Market Growth

Which Factors are Restraining Growth?
. Strict Regulatory Scenarios to Hamper Market Growth
. Rising Antibiotic Resistance to Restrain Market Growth

How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.

Discover how to stay ahead

Our 640+ pages report provides 900+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibiotics Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
. In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
. You find original analyses, with business outlooks and developments.
. Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Drug Class
. Cephalosporin
. Penicillin
. Fluoroquinolone
. Macrolide
. Carbapenem
. Aminoglycoside
. Sulfonamide
. 7-ACA
. Others

Action Mechanism
. Cell Wall Synthesis Inhibitors
. Protein Synthesis Inhibitors
. DNA Synthesis Inhibitors
. RNA Synthesis Inhibitors
. Mycolic Acid Inhibitors
. Others

. Male
. Female

. 0-14 years
. 15-54 years
. 55 years and above

Route of Administration
. Oral
. Intravenous
. Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 26 national markets:

By Region
. North America
. U.S.
. Canada
. Europe
. Germany
. UK
. France
. Italy
. Spain
. Russia
. Denmark
. Norway
. Sweden
. Finland
. Netherlands
. Rest of Europe
. Asia Pacific
. China
. Japan
. India
. Australia
. Singapore
. Malaysia
. Sri Lanka
. Rest of APAC
. Latin America
. Brazil
. Mexico
. Argentina
. Colombia
. Rest of Latin America
. Middle East and Africa
. South Africa
. Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Antibiotics Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which regions hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market

Including company profiles for 16 of the major companies involved in the antibiotics market. Some of the companies profiled in this report include Abbott Laboratories, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Viatris (Mylan), Novartis International AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Cipla Ltd., Allergan (AbbVie Inc.), Cumberland Pharmaceuticals, Inc., LUPIN, Melinta Therapeutics LLC, Amneal Pharmaceuticals LLC, and WOCKHARDT.

Key Questions Answered by this Report:
. What is the current size of the overall global antibiotics market? How much will this market be worth from 2021 to 2031?
. What are the main drivers and restraints that will shape the overall antibiotics market over the next ten years?
. What are the main segments within the overall antibiotics market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
. What factors will affect that industry and market over the next ten years?
. What are the largest national markets for the world antibiotics? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
. How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
. Which are the leading companies and what are their activities, results, developments, and prospects?
. What are the main trends that will affect the world antibiotics market between 2021 and 2031?
. What are the main strengths, weaknesses, opportunities, and threats for the market?
. How will the global antibiotics market evolve over the forecasted period, 2021 to 2031?
. How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting